Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Creative Media & Community Trust | CMCT | Apr 18, 2024 | 3.32 | -4.05 |
Creative Medical Technology | CELZ | Apr 18, 2024 | 4.81 | -3.70 |
Creative Realities | CREX | Apr 18, 2024 | 3.11 | -0.16 |
Credicorp | BAP | Apr 18, 2024 | 161.88 | +0.55 |
Credit Acceptance | CACC | Apr 18, 2024 | 536.40 | +0.72 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Apr 18, 2024 | 26.64 | +0.41 |
Credit Suisse Ag | SLVO | Apr 18, 2024 | 80.25 | +0.21 |
Credit Suisse Ag | GLDI | Apr 18, 2024 | 152.92 | +0.23 |
Credit Suisse Asset Management Income Fund | CIK | Apr 18, 2024 | 2.86 | -0.02 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Apr 18, 2024 | 76.40 | -0.01 |
Credit Suisse High Yield Bond Fund | DHY | Apr 18, 2024 | 1.98 | 0.00 |
Credo Technology | CRDO | Apr 18, 2024 | 17.99 | -3.23 |
Crescent Capital BDC | CCAP | Apr 18, 2024 | 17.08 | +0.47 |
Crescent Energy | CRGY | Apr 18, 2024 | 10.79 | -2.35 |
Crescent Point Energy | CPG | Apr 18, 2024 | 8.45 | -0.71 |
Cresud A ADR | CRESY | Apr 18, 2024 | 8.78 | +0.57 |
Crexendo | CXDO | Apr 18, 2024 | 4.12 | -3.51 |
CRH | CRH | Apr 18, 2024 | 77.14 | -1.76 |
Cricut A | CRCT | Apr 18, 2024 | 5.18 | +3.81 |
Crinetics Pharmaceuticals | CRNX | Apr 18, 2024 | 43.01 | -2.27 |
CRISPR Therapeutics | CRSP | Apr 18, 2024 | 56.16 | +1.08 |
Criteo ADR | CRTO | Apr 18, 2024 | 34.36 | +0.91 |
Critical Metals | CRML | Apr 18, 2024 | 8.40 | 0.00 |
Crocs | CROX | Apr 18, 2024 | 121.08 | +1.47 |
Cronos Group | CRON | Apr 18, 2024 | 2.41 | -0.41 |
Cross Country Healthcare | CCRN | Apr 18, 2024 | 17.13 | +1.48 |
Cross Timbers Royalty Royalty Trust | CRT | Apr 18, 2024 | 13.14 | -0.15 |
CrossAmerica Partners LP Unit | CAPL | Apr 18, 2024 | 22.35 | +0.72 |
CrossFirst Bankshares | CFB | Apr 18, 2024 | 12.06 | +2.12 |
CrowdStrike A | CRWD | Apr 18, 2024 | 294.10 | +0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.